Remove 2025 Remove Patent Infringement Remove Settlement
article thumbnail

Biocon Settles with Bayer and Regeneron, Securing Canada Market Entry Date for Aflibercept Biosimilar

LexBlog IP

announced it has signed a settlement agreement with Bayer Inc. The settlement resolves multiple patent infringement proceedings in the Federal Court of Canada. Under the agreement, Biocon can launch YESAFILI in Canada no later than July 1, 2025. On March 4, Biocon Biologics Ltd. and Regeneron Pharmaceuticals, Inc.

article thumbnail

Analysis of February 2024 Delhi High Court Judgment in InterDigital v. Oppo – I

SpicyIP

Background The Petitioner, InterDigital (“ID”), initiated patent infringement proceedings against Oppo, One Plus and Redme (“defendants”) concerning 8 standard essential patents. These patents concern wireless communication technology standards (IN 262910, 295912, 313036, 319673, 320182) and H.265

article thumbnail

Presumption of Injunction: How the RESTORE Act Aims to Re-Empower Patent Holders

Patently-O

by Dennis Crouch For the vast majority of American history, a judgment of patent infringement (by a court sitting in equity) led almost directly to injunctive relief barring ongoing infringement. Adam Mossoff, Injunctions for Patent Infringement: Historical Equity Practice Between 1790 – 1882 , Harvard J.

Patent 53